Association of serum omentin-1 levels with coronary artery disease.
about
Joint analysis of left ventricular expression and circulating plasma levels of Omentin after myocardial ischemia.Omentin-1 is decreased in maternal plasma, placenta and adipose tissue of women with pre-existing obesity.Decreased levels of serum omentin-1 in patients with inflammatory bowel diseaseAssociation of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes.Omentin as a novel biomarker of metabolic risk factors.Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study.New Insights into the Role of Metformin Effects on Serum Omentin-1 Levels in Acute Myocardial Infarction: Cross-Sectional Study.Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease.Serum omentin-1 as a disease activity marker for Crohn's disease.Analysis of pericardial effusion from idiopathic pericarditis patients by two-dimensional gel electrophoresis.Adipokines and the cardiovascular system: mechanisms mediating health and disease.Adipokines, vascular wall, and cardiovascular disease: a focused overview of the role of adipokines in the pathophysiology of cardiovascular disease.Serum levels of omentin-1 are increased after weight loss and are particularly associated with increases in obese children with metabolic syndrome.Relationship of circulating chemerin and omentin levels with Th17 and Th9 cell immune responses in patients with asthma.Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity.Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism.Soluble intracellular adhesion molecule-1 and omentin-1 as potential biomarkers of subclinical atherosclerosis in hemodialysis patients.Association of Serum Omentin-1 Concentrations with the Presence of Atrial Fibrillation.Omentin-1 effects on mesenchymal stem cells: proliferation, apoptosis, and angiogenesis in vitro.Association of single Nucleotide Missence Polymorphism Val109Asp of Omentin-1 gene and coronary artery disease in Pakistani population: Multicenter study.Decreased levels of serum omentin-1 in patients with obstructive sleep apnoea syndrome.Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease.Omentin-A Novel Adipokine in Respiratory Diseases.Association between continuous positive airway pressure and circulating omentin levels in patients with obstructive sleep apnoea.Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension.Omentin treatment of epicardial fat improves its anti-inflammatory activity and paracrine benefit on smooth muscle cells.Modulatory Role of Omentin-1 in Inflammation: Cytokines and Dietary Intake.
P2860
Q33883211-879B0DE3-691A-4C77-A4D3-04EBC088ECFEQ34404890-A31D9F71-5D16-446F-8D1B-9E849B754086Q34982144-D88D04FF-5EEC-4B5F-B2EA-9D122CCCC760Q35607765-C14C5611-ECF2-4A53-A3FD-EF4A37309A9FQ36138940-2014347A-1D27-4B5B-859E-E2DCE40AE608Q36163654-87E0B52E-3738-49BB-B4F4-6691E537E456Q36349750-C8B77BE8-D98F-42B1-B776-08180E67062CQ36951691-275201D2-296E-4B1D-B4BB-DE6080EFB2AFQ37514552-7503AABE-7342-4771-9076-AABCB718EA0AQ37603086-1D9D565C-CA87-4B45-9A15-12798E99C93AQ37718879-0B87C022-E311-468C-BD46-D96B20DB35B7Q38014474-DAB10E76-AFD8-4E3D-885F-B102B67AB53DQ38188874-4CEF919A-0923-4924-BA24-E24EA8B44F22Q38612064-03E1E9B2-F940-4167-9B98-7703470E9701Q38644577-B834A535-985E-48C8-B787-9B6E870B1CA1Q39175599-CF947BBE-6774-4372-883A-643E04DEEC36Q40082493-E08AF610-8F94-42CA-907D-1B41A0346DF6Q40829122-CAC197FA-0ACD-4F06-A8FB-EBD3A131A0B9Q42356917-9ECCDC11-42EF-41F9-BE50-9400E97DD45BQ42373535-EE510961-EE0B-4370-8789-221BD47AD3B0Q43405165-46FFB793-6A1A-41DA-A28C-2D9C21F3F48DQ43901982-EC8BD4A8-4A6F-4025-9630-F43CFA29C659Q46074545-393325F8-342A-4740-9FC9-C3E306646B58Q47650367-43E4E80F-0FAE-4FFC-95B2-F45CB4CAA458Q47895046-65CB4E4E-AA94-4E78-A411-C76A766D2FAEQ48005805-ED62E265-DA2A-45EF-934D-21E2BF34410DQ48248803-B12A8FCC-5C5B-49E7-8FD3-5FDE514FB331Q51282867-C2009C27-0D9D-4F16-8468-7C8E85F1DF47
P2860
Association of serum omentin-1 levels with coronary artery disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of serum omentin-1 levels with coronary artery disease.
@en
Association of serum omentin-1 levels with coronary artery disease.
@nl
type
label
Association of serum omentin-1 levels with coronary artery disease.
@en
Association of serum omentin-1 levels with coronary artery disease.
@nl
prefLabel
Association of serum omentin-1 levels with coronary artery disease.
@en
Association of serum omentin-1 levels with coronary artery disease.
@nl
P2093
P2860
P356
P1476
Association of serum omentin-1 levels with coronary artery disease.
@en
P2093
De-ya Shang
Fu-qin Chen
Hai-yang Zhang
P2860
P2888
P304
P356
10.1038/APS.2011.26
P577
2011-05-23T00:00:00Z